GLP-2 Tirze

Tirze is a dual-pathway peptide analog studied for its interaction with GLP-1 and GIP receptor systems. Research use includes evaluating nutrient-response signaling, receptor binding, and peptide kinetics in controlled laboratory settings.

How Tirze Works

Research shows that Tirzepatide is a dual incretin agonist that activates both GLP-1 and GIP receptors, producing synergistic effects on appetite, insulin regulation, and fat metabolism

GLP-1 activation reduces hunger, slows gastric emptying, and supports glucose control, while GIP activation enhances insulin sensitivity and energy utilization. Together, these pathways promote greater fat loss, improved glycemic stability, and enhanced metabolic efficiency

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE. NOT FOR HUMAN CONSUMPTION.